Navigation Links
Subsidies For GPs' Visits : Agreement Reached

Dialogues between District Health Boards and Primary Health Organisations, (PHOs), which faced difficulties late last month, has now been resolved //, with both parties reaching an agreement on the extension of subsidies for doctors' visits.

An estimated 680,000 New Zealanders who are GP patients, aged between 45 - 64 years, are expected to benefit from July 1.

DHBs and GPs have long been at loggerheads over the conditions, with the GPs refusing to sign a proposed agreement concerning the subsidy rollout, saying it was an attempt to control their fees.

The new agreement does not require GPs to acquire approval of future fee increases , instead , strengthens review mechanisms of fees. It directs GPs to be advised on refund of fees if patients are considered to have paid an extra amount, says Radio New Zealand's health correspondent.Family doctors are required to publicise their fees under the deal.

Health Minister, Pete Hodgson, says that the agreement will ensure that the subsidy is ' not misappropriated’ and adds that the indications are that the majority of PHOs will sign the agreement.

Peter Foley, GPs' spokesman, says he's pleased that commonsense has prevailed.


'"/>




Page: 1

Related medicine news :

1. Agricultural Subsidies Responsible For Obesity, Says Expert
2. New Zealand’s Pharmac Subsidies Two More HIV Drug
3. Prime Minister Visits the Proposed Super Hospital Site
4. Door-to-door Visits to Check Water-borne and Seasonal Diseases in Rajasthan
5. Agreement To Speed Up Development of Bird flu vaccine
6. MIOT Hospital Signs Agreement With German Healthcare Facility
7. Strained Economic Agreement Between Singapore And India
8. Ranbaxy Signs Agreement With Zenotech For Cancer Drugs
9. Agreement for Joint Trials of Avian Flu Vac cine on Humans
10. Ranbaxy Signs Licensing, Supply Agreement for Canadian Market
11. Indo-Fiji Agreement in Field of Health, Medicine Approved
Post Your Comments:
(Date:7/9/2008)...l Research Warranted on Impact of Medicare Moderni...enges; Data Shows Possibility of,Longer Wait Times...y 9 /PRNewswire-USNewswire/ -- According to a new ...nal of the American Medical,Association (JAMA), ca...r,access to quality cancer care following the pass...
(Date:7/9/2008)...pneumococcal vaccine (Prevenar) was introduced in ... years later, the experiences have been published ...g decline in serious pneumococcal infections among...that can cause serious illnesses in some young chi...nia. Most of those who become ill are previously h...
(Date:7/9/2008)...c outcome after lumpectomy linked to depression, f...HealthDay News) -- A third of women who opt for br...n asymmetry between their breasts that greatly aff... Women whose affected breast looked noticeably dif...their cancer returning and to have symptoms of dep...
(Date:7/9/2008)...ed MCO Pharmacy Directors Will Move Razadyne and R...dyne is Launched, According to a New ...ass., July 9 /PRNewswire/ -- Decision Resources, o...rms for pharmaceutical and,healthcare issues, find...rtho McNeil,s Razadyne (galantamine) in December 2...
Breaking Medicine News(10 mins):Health News:Global Access Project (GAP) Study Examining Patients' Access to Cancer Care Featured in the Journal of the American Medical Association (JAMA) 2Health News:Vaccinated infants well-protected against severe pneumococcal infection in Norway 2Health News:Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 2Health News:Primary Care Physicians' Prescriptions of Aricept for Alzheimer's Disease Will Drop by 20 Percent Following the Availability of Generic Razadyne in December 2008 3
...ost half of all newly-diagnosed lung cancer cases.... do not disappear as soon as people quit, as it ta...en found that smoking causes genetic damage in the... from becoming cancerous. Researchers from the Uni...
...ched the first two head-to-head clinical trials th...x (alendronate) once weekly 70mg and Actonel (rise...th bisphosphonates indicated for the treatment of ...keted by Aventis and Procter & Gamble through the ...
...n children, which lead to chronic health problems ...ediatricians in the treatment of obesity in childr... kids are getting. A recent study has shown that c...aking them fall short of the American National gui...
...on people go to the Emergency Room(ER) with chest ...t receive an ECG and other standard tests to deter...rious heart problems. However, ECGs can be complet...ce. ECGs are also sometimes unable to identify uns...
Other Medicine News:
(Date:7/8/2008)... SAN MATEO, Calif., July 8 /- After m...ecommended that all new diabetes drugs should,unde... US cardiologists and,65% of US endocrinologists a...etail Inc., a leader in cardiovascular and metabol...mapping solutions to the Global Life,Sciences Indu...
(Date:7/8/2008)... 96-week comparative study of Clevudine versus ...atients with chronic hepatitis B, PRINCETON, N.J....onal,Agency for Research on AIDS and Viral Hepatit...asdaq: VRUS ) and Gilead Sciences, Inc. (Nasdaq: ...y of clevudine and Viread(R),(tenofovir disoproxil...
(Date:7/7/2008)...olecular Biometrics presents scientific evidence s... metabolomics platform at major international ...Spain and CHESTER, N.J., July 7 /- Mo...mics company developing novel,clinical tools for a...ately,characterize biologic function in health and...
(Date:7/7/2008)... New Study Suggests Kiwifruit is Top Performe...t all fruits are created equal when,it comes to th...mong the,highest in bioavailability compared to ot...t small-scale study published in the Journal of th...clude vitamins and phytochemicals called flavonoid...
Breaking Medicine Technology:AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 3Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 4Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 2Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 3Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology 4Kiwifruit: Antioxidant Power in Quantity and Quality 2Childrens Hospital Boston Ranked Number One in New England 20636 1Childrens Hospital Boston Ranked Number One in New England 20636 2Childrens Hospital Boston Ranked Number One in New England 20636 3A common aquatic animals genome can capture foreign DNA 3478 1A common aquatic animals genome can capture foreign DNA 3478 2Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 1Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 2Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 3Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 4Three Miami Area Doctors and Six Others Charged in 2456 Million Health Care Fraud Schemes 20635 5U S News 2008 Best Hospitals Issue Again Ranks Packard Childrens as One of Nations Best 20633 1U S News 2008 Best Hospitals Issue Again Ranks Packard Childrens as One of Nations Best 20633 2
...OLIS, France, May 11, 2007 /PRNewswire-FirstCall/ ...date on the phase 2a,study for NCX 1000, which is ...Pharma Inc. A preliminary analysis of 11 patients...ension confirmed,the safety profile of NCX 1000 bu...port the continuation of this clinical trial. As a...
...tional vaccine could offer protection,for infants ...ococcal disease , , TORONTO, Canada, May 11...results from a,Phase II vaccine clinical study pre...es’ (PAS) Annual Meeting in,Toronto, Canada....-MenCY-TT vaccine holds potential to protect infan...
Other Medicine Technology:NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 2NicOx Provides an Update on the Phase 2a Study for NCX 1000,Conducted With Axcan 3GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 2GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 3GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 4GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets,Phase II Study Endpoints of Immunogenicity and Safety Compared to,Licensed Vaccines 5
Full Handle Laseredge Stab Blade Knife, 22.5 blade. Blade tip dimension: 10.7 mm x 1.8 mm x 4.2 mm.
19 Gauge. Reusable. Block of 4 each.
18 gauge curved. Fine tip. Lightweight design offers precise hemostasis. Pencil design minimizes tissue trauma and induced astigmatism. Knurled handle provides a sure grip and better manipulation.
Set consist of two 23 gauge, stainless steel probes with blunt tips. Probes are 18 cm (7.0 inches) long with 30.5 cm (12 inches) of flexible tubing (O.D. - 0.60 mm, I.D. - 0.30 mm) attached onto the
Medicine Products: